Febrile infection-related epilepsy syndrome treated with anakinra

Annals of Neurology

Volumn 80, Issue 6, 2016, Pages 939-945

  Kenney Jung, Daniel L ^a   Vezzani, Annamaria ^b   Kahoud, Robert J ^a   LaFrance Corey, Reghann G ^a   Ho, Mai Lan ^a   Muskardin, Theresa Wampler ^a   Wirrell, Elaine C ^a   Howe, Charles L ^a   Payne, Eric T ^a  

^a MAYO CLINIC   (United States)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FELBAMATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEVETIRACETAM; METHYLPREDNISOLONE; MIDAZOLAM; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENOBARBITAL; RANTES; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR; AUTACOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN;

ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXTRACORPOREAL OXYGENATION; FEBRILE INFECTION RELATED EPILEPSY SYNDROME; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; KETOGENIC DIET; MORNING DOSAGE; NEUROIMAGING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TONIC CLONIC SEIZURE; TREATMENT DURATION; CEREBROSPINAL FLUID; COMPLICATION; INFECTIOUS ENCEPHALITIS; SEIZURES, FEBRILE; STATUS EPILEPTICUS; SYNDROME;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFECTIOUS ENCEPHALITIS; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECOMBINANT PROTEINS; SEIZURES, FEBRILE; STATUS EPILEPTICUS; SYNDROME;

EID: 85006409436     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24806     Document Type: Article

References (22)

1. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 2011;52:1956–1965.
2. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033–2037.
3. Singh RK, Joshi SM, Potter DM, et al. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014;134:e1431–e1435.
4. Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 2012;11:633–652.
5. Vezzani A, Maroso M, Balosso S, et al. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011;25:1281–1289.
6. Dube C, Vezzani A, Behrens M, et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005;57:152–155.
7. Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479–1486.
8. ter Haar NM, Oswald M, Jeyaratnam J, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis 2015;74:1636–1644.
9. Vezzani A, Moneta D, Conti M, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000;97:11534–11539.
10. Mazzuca M, Jambaque I, Hertz-Pannier L, et al. 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011;52:40–47.
11. van Baalen A, Hausler M, Plecko-Startinig B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 2012;43:209–216.
12. Appenzeller S, Helbig I, Stephani U, et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol 2012;54:1144–1148.
13. Illingworth MA, Hanrahan D, Anderson CE, et al. Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol 2011;53:1053–1057.
14. Specchio N, Fusco L, Vigevano F. Acute-onset epilepsy triggered by fever mimicking FIRES (febrile infection-related epilepsy syndrome): the role of protocadherin 19 (PCDH19) gene mutation. Epilepsia 2011;52:e172–e175.
15. Payne ET, Hahn CD. Continuous electroencephalography for seizures and status epilepticus. Curr Opin Pediatr 2014;26:675–681.
16. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia 2011;52(suppl 8):28–30.
17. Sakuma H, Tanuma N, Kuki I, et al. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry 2015;86:820–822.
18. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol 2013;244:11–21.
19. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002;43(suppl 5):30–35.
20. Sibley CH, Plass N, Snow J, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum 2012;64:2375–2386.
21. Urien S, Bardin C, Bader-Meunier B, et al. Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes. BMC Pharmacol Toxicol 2013;14:40.
22. Kullenberg T, Lofqvist M, Leinonen M, et al. Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes. Rheumatology (Oxford) 2016;55:1499–1506.